Tick-borne encephalitis (Q31157187)

29 June 2017

1 reference

title

Tick-borne encephalitis (English)

1 reference

29 June 2017

tick-borne encephalitis

0 references

author name string

Lars Lindquist

series ordinal

1

1 reference

PubMed ID

18514730

29 June 2017

Olli Vapalahti

series ordinal

2

1 reference

PubMed ID

18514730

29 June 2017

language of work or name

English

0 references

publication date

1 May 2008

1 reference

29 June 2017

1 reference

29 June 2017

371

1 reference

29 June 2017

1861-1871

1 reference

29 June 2017

9627

1 reference

29 June 2017

Tick-borne encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Tick‐Borne Encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Epidemiology and ecology of TBE relevant to the production of effective vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Tick-borne flaviviruses.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Flavivirus structure and membrane fusion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Molecular biology of flaviviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Recombinant and virion-derived soluble and particulate immunogens for vaccination against tick-borne encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Diagnosis of Tick-Borne Encephalitis by a -Capture Immunoglobulin M-Enzyme Immunoassay Based on Secreted Recombinant Antigen Produced in Insect Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Mimicking live flavivirus immunization with a noninfectious RNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Genetic characterization of tick-borne flaviviruses: new insights into evolution, pathogenetic determinants and taxonomy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Phylogenetic relationships of flaviviruses correlate with their epidemiology, disease association and biogeography

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Characterization of tick-borne encephalitis virus from Latvia: evidence for co-circulation of three distinct subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Distribution and characterization of tick-borne encephalitis viruses from Siberia and far-eastern Asia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Characterization of tick-borne encephalitis virus from Estonia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Geographical distribution, host associations, and vector roles of ticks (Acari: Ixodidae, Argasidae) in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Characterisation of human tick‐borne encephalitis virus from Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Siberian subtype tickborne encephalitis virus, Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Molecular epidemiology of tick-borne encephalitis virus in Ixodes ricinus ticks in Lithuania

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Migrating Birds and Tickborne Encephalitis Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Family outbreak of alimentary tick-borne encephalitis in Slovakia associated with a natural focus of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Tick-borne viral encephalitis in Finland. The clinical features of Kumlinge disease during 1959-1987.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Laboratory acquired tick-borne meningoencephalitis: characterisation of virus strains.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Ticks and tickborne bacterial diseases in humans: an emerging infectious threat

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

The clinical and epidemiological profile of tick-borne encephalitis in southern Germany 1994-98: a prospective study of 656 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Pediatric tick-borne encephalitis in 371 cases from an endemic region in Slovenia, 1959 to 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Tickborne encephalitis in an area of high endemicity in lithuania: disease severity and long-term prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

The shifting landscape of tick-borne zoonoses: tick-borne encephalitis and Lyme borreliosis in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

A 10-year follow-up study of tick-borne encephalitis in the Stockholm area and a review of the literature: need for a vaccination strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

TBE vaccination and the Austrian experience

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Serological evidence for tick-borne encephalitis, borreliosis, and human granulocytic anaplasmosis in Mongolia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Fragile transmission cycles of tick-borne encephalitis virus may be disrupted by predicted climate change

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Objective assessment of risk maps of tick-borne encephalitis and Lyme borreliosis based on spatial patterns of located cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Non-viraemic transmission of tick-borne encephalitis virus: a mechanism for arbovirus survival in nature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Tick-borne encephalitis virus transmission between ticks cofeeding on specific immune natural rodent hosts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Importance of localized skin infection in tick-borne encephalitis virus transmission.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Enhancement of tick-borne encephalitis virus transmission by tick salivary gland extracts.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Incidence from coincidence: patterns of tick infestations on rodents facilitate transmission of tick-borne encephalitis virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Seasonal synchrony: the key to tick-borne encephalitis foci identified by satellite data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Sacred cows and sympathetic squirrels: the importance of biological diversity to human health

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Shift of the Tick Ixodes ricinus and Tick-Borne Encephalitis to Higher Altitudes in Central Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Impact of climatic change on the northern latitude limit and population density of the disease-transmitting European tick Ixodes ricinus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Tick-borne encephalitis in Sweden and climate change

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Climate Change Cannot Explain the Upsurge of Tick-Borne Encephalitis in the Baltics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Tick-borne encephalitis in the Baltic States: identifying risk factors in space and time

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Ticks and tick-borne disease systems in space and from space

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Tick-bone encephalitis in Sweden in relation to aseptic meningo-encephalitis of other etiology: a prospective study of clinical course and outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Thrombocytopenia--a common finding in the initial phase of tick-borne encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Prevalence of tick-borne encephalitis and Lyme borreliosis in a defined Swedish population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Two-year survey of the incidence of Lyme borreliosis and tick-borne encephalitis in a high-risk population in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Central european tick-borne encephalitis from 1969 to 1972 in central bohemia (author's transl)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Tick-borne encephalitis in north-eastern Poland in 1997-2001: a retrospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

TBE in Aland Islands 1959-2005: Kumlinge disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

MRI abnormalities in tick-borne encephalitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Magnetic resonance imaging findings and outcome in severe tick-borne encephalitis. Report of four cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Severe forms of tick-borne meningoencephalitis in Slovenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Tick-borne encephalitis in southwestern Germany.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Spread of early-summer meningoencephalitis in the Federal Republic of Germany

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Epidemiology of tick-borne encephalitis in Sweden 1956-1989: a study of 1116 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Tick-borne encephalitis in a 3-month-old child

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Tick-borne meningo-encephalitis in a 6-week-old infant

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

[Tick-borne encephalitis in children (author's transl)]

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Tick-borne encephalitis in Styrian children from 1981 to 2005: a retrospective study and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Tick-borne encephalitis in a 17-day-old newborn resulting in severe neurologic impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Tickborne encephalitis despite specific immunoglobulin prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Laboratory findings in tick-borne encephalitis--correlation with clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Intrathecal IgM, IgA and IgG antibody response in tick-borne encephalitis. Long-term follow-up related to clinical course and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Molecular aspects of TBE virus research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

The molecular basis of virulence of the encephalitogenic flaviviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Visualization of Central European tick-borne encephalitis infection in fatal human cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Intrathecal production of neopterin and beta 2 microglobulin in tick-borne encephalitis (TBE) compared to meningoencephalitis of other etiology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Main features of tick-borne encephalitis eco-epidemiology in Russia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Clinical manifestations and antibody prevalence of Lyme borreliosis and tick-borne encephalitis in Sweden: a study in five endemic areas close to Stockholm

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Specific clinical and epidemiological features of tick-borne encephalitis in Western Siberia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Characterization of a siberian virus isolated from a patient with progressive chronic tick-borne encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Chronic tick-borne encephalitis virus antigenemia: possible pathogenesis pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Identification of tick-borne encephalitis virus ribonucleic acid in tick suspensions and in clinical specimens by a reverse transcription-nested polymerase chain reaction assay

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Diagnosis of tick-borne encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Evaluation of European tick-borne encephalitis virus vaccine against recent Siberian and far-eastern subtype strains

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Molecular epidemiology of tick-borne encephalitis virus: cross-protection between European and Far Eastern subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Immunogenicity and reactogenicity of a highly purified vaccine against tick‐borne encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

An accelerated schedule for tick-borne encephalitis vaccine: the American Military experience in Bosnia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Protection against tick-borne encephalitis virus isolated in Japan by active and passive immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: results of two large phase 3 clinical studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Kinetics of the immune response after primary and booster immunization against tick-borne encephalitis (TBE) in adults using the rapid immunization schedule

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Clinical evaluation of a polygeline-free tick-borne encephalitis vaccine for adolescents and adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Immunogenicity and safety of a booster vaccination against tick-borne encephalitis more than 3 years following the last immunisation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Two severe cases of tick-borne encephalitis despite complete active vaccination--the significance of neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

The Golden Agers and Tick-borne encephalitis. Conference report and position paper of the International Scientific Working Group on Tick-borne encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Antibody response to gp E of tick-borne encephalitis virus: comparison between natural infection and vaccination breakdown

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Tick-borne encephalitis: development of a paediatric vaccine. A controlled, randomized, double-blind and multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Insufficient protection for healthy elderly adults by tetanus and TBE vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

TBE booster immunization according to the rapid immunization schedule: are 3-year booster intervals really necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Persistence of protective immunity following vaccination against tick-borne encephalitis--longer than expected?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Tick-borne encephalitis (TBE) vaccination: applying the most suitable vaccination schedule.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

[Postvaccinal neuritis following prophylactic vaccination against early-summer meningo-encephalitis]

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Safety, immunogenicity and tolerability of a new pediatric tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

Tolerability of modified tick-borne encephalitis vaccine FSME-IMMUN "NEW" in children: results of post-marketing surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960800-4

7 January 2021

10.1016/S0140-6736(08)60800-4

Identifiers

DOI

1 reference

29 June 2017

1 reference

PubMed ID

18514730